drugset / Trial / NCT02028689

Metformin and Furosemide Drug-Drug Interaction Study

NCT02028689

Phase 1 Completed 23 enrolled Ardea Biosciences, Inc.
RandomizedParallel-groupOpen-labelBasic science

Summary

This study will assess the potential effects of lesinurad on the pharmacokinetics (PK) of metformin and furosemide in healthy, adult male subjects.

Timeline

Start
2013-10
Primary completion
2013-11
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 40 mg
Subject Lesinurad Small molecule 400 mg
Subject Metformin Small molecule 850 mg

Indications

No indication recorded.